0001209191-15-080796.txt : 20151117
0001209191-15-080796.hdr.sgml : 20151117
20151117214514
ACCESSION NUMBER: 0001209191-15-080796
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151117
FILED AS OF DATE: 20151117
DATE AS OF CHANGE: 20151117
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Revance Therapeutics, Inc.
CENTRAL INDEX KEY: 0001479290
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770551645
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7555 GATEWAY BLVD.
CITY: NEWARK
STATE: CA
ZIP: 94560
BUSINESS PHONE: 510-742-3400
MAIL ADDRESS:
STREET 1: 7555 GATEWAY BLVD.
CITY: NEWARK
STATE: CA
ZIP: 94560
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bertolino Arthur Peter
CENTRAL INDEX KEY: 0001426344
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36297
FILM NUMBER: 151239527
MAIL ADDRESS:
STREET 1: 6475 CHRISTIE AVENUE SUITE 300
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-11-17
0
0001479290
Revance Therapeutics, Inc.
RVNC
0001426344
Bertolino Arthur Peter
C/O REVANCE THERAPEUTICS, INC.
7555 GATEWAY BOULEVARD
NEWARK
CA
94560
0
1
0
0
EVP and Chief Medical Officer
Common Stock
2015-11-17
4
S
0
5425
39.11
D
36329
D
Common Stock
2015-11-17
4
S
0
36
39.55
D
36293
D
Common Stock
2015-11-17
4
S
0
2277
39.11
D
34016
D
Common Stock
2015-11-17
4
S
0
15
39.55
D
34001
D
The Reporting Person sold an aggregate of 5,461 shares of restricted stock to settle a personal tax liability in connection with the November 15, 2015 vesting of certain shares of restricted stock that the Reporting Person acquired pursuant to a grant dated September 2, 2014.
The Reporting Person sold an aggregate of 2,292 shares of restricted stock to settle a personal tax liability in connection with the November 15, 2015 vesting of certain shares of restricted stock that the Reporting Person acquired pursuant to a grant dated January 28, 2015.
/s/ Gordon Ho, Attorney-in-fact
2015-11-17